BREAST ADENOCARCINOMA
Clinical trials for BREAST ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for BREAST ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: new combo shows promise against tough breast cancer
Disease control CompletedThis phase II trial tested a combination of two targeted antibodies (pertuzumab and trastuzumab) plus a chemotherapy drug (nab-paclitaxel) in 63 patients with HER2-positive advanced breast cancer. The goal was to see how well the drugs work together to stop tumor growth and impro…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Personalized vitamin d dosing may beat standard approach in breast cancer patients
Disease control CompletedThis study tested whether giving vitamin D based on a patient's deficiency level works better than a standard dose. 215 breast cancer patients on chemotherapy received either a fixed daily supplement or a tailored dose. The goal was to see which method normalizes vitamin D levels…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo shows promise in shrinking aggressive breast tumors before surgery
Disease control CompletedThis study tested a combination of chemotherapy (nab-paclitaxel) and immunotherapy (atezolizumab) given before surgery to women with triple-negative breast cancer. The goal was to shrink tumors and reduce the amount of breast tissue that needs to be removed. The trial involved 37…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a One-Week radiation course be just as good as three weeks for breast cancer?
Disease control CompletedThis completed study tested whether a shorter, more intense course of radiation (1 week) works as well as the standard 3-week course for women with early breast cancer after lumpectomy. Sixty women were split into two groups to compare side effects, cosmetic results, and cancer c…
Matched conditions: BREAST ADENOCARCINOMA
Phase: NA • Sponsor: Zagazig University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pain block could replace standard for breast surgery
Symptom relief CompletedThis study tested whether a newer nerve block called ESP works as well as the standard PVB block for pain after breast cancer surgery. 292 women received one of the two blocks before surgery. The main goal was to see how many needed morphine in the first two hours after surgery. …
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE4 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Jun 26, 2026 18:54 UTC